December 21, 2015—Healthcare providers that can’t obtain 340B pricing on a covered outpatient drug and can’t get satisfaction from their wholesaler and/or the drug manufacturer shouldn’t hesitate to bring the problem to the government’s attention, federal officials say.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)